Allogeneic Hematopoietic Cell Transplantation in Children with Relapsed Acute Lymphoblastic Leukemia Isolated to the Central Nervous System

Biology of Blood and Marrow Transplantation

Volumn 14, Issue 6, 2008, Pages 685-692

  Harker Murray, Paul D ^a   Thomas, Avis J ^a   Wagner, John E ^a   Weisdorf, Daniel ^a   Luo, Xianghua ^a   DeFor, Todd E ^a   Verneris, Michael R ^a   Dusenbery, Kathryn E ^a   MacMillan, Margaret L ^a   Tolar, Jakub ^a   Baker, K Scott ^a   Orchard, Paul J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Acute lymphocytic leukemia; Bone marrow; CNS relapse; Graft versus host disease; Stem cell; Umbilical cord blood

Indexed keywords

BCR ABL PROTEIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; FLUDARABINE;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BONE MARROW CANCER; BONE MARROW TRANSPLANTATION; CANCER MORTALITY; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CHILD; CHILDHOOD CANCER; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORD BLOOD STEM CELL TRANSPLANTATION; DISEASE FREE SURVIVAL; DONOR; FEMALE; GENE REARRANGEMENT; HLA MATCHING; HUMAN; LEUKEMIA RELAPSE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; ONSET AGE; OUTCOMES RESEARCH; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SURVIVAL RATE; SURVIVAL TIME; T CELL LEUKEMIA;

ADOLESCENT; AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW TRANSPLANTATION; CENTRAL NERVOUS SYSTEM; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; CORD BLOOD STEM CELL TRANSPLANTATION; CRANIAL IRRADIATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; LEUKEMIC INFILTRATION; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RADIOTHERAPY, ADJUVANT; RECURRENCE; REMISSION INDUCTION; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 43449139122     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2008.03.011     Document Type: Article

References (32)

1. Pui C.H. Central nervous system disease in acute lymphoblastic leukemia: prophylaxis and treatment. Hematology Am Soc Hematol Educ Program (2006) 142-146
2. Nguyen K., Cheng S.-C., Raetz E., et al. Factors influencing survival after relapse from childhood ALL: a Children's Oncology Group Study. ASH Ann Meet Abstr 108 (2006) 1855
3. Hutchinson R.J., Gaynon P.S., Sather H., et al. Intensification of therapy for children with lower-risk acute lymphoblastic leukemia: long-term follow-up of patients treated on Children's Cancer Group Trial 1881. J Clin Oncol 21 (2003) 1790-1797
4. Bostrom B.C., Sensel M.R., Sather H.N., et al. Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 101 (2003) 3809-3817
5. Lange B.J., Bostrom B.C., Cherlow J.M., et al. Double-delayed intensification improves event-free survival for children with intermediate-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group. Blood 99 (2002) 825-833
6. Ritchey A.K., Pollock B.H., Lauer S.J., Andejeski Y., Barredo J., and Buchanan G.R. Improved survival of children with isolated CNS relapse of acute lymphoblastic leukemia: a pediatric oncology group study. J Clin Oncol 17 (1999) 3745-3752
7. Barredo J.C., Devidas M., Lauer S.J., et al. Isolated CNS relapse of acute lymphoblastic leukemia treated with intensive systemic chemotherapy and delayed CNS radiation: a pediatric oncology group study. J Clin Oncol 24 (2006) 3142-3149
8. Barker J.N., Hough R.E., van Burik J.A., et al. Serious infections after unrelated donor transplantation in 136 children: impact of stem cell source. Biol Blood Marrow Transplant 11 (2005) 362-370
9. Davies S.M., Wagner J.E., Shu X.O., et al. Unrelated donor bone marrow transplantation for children with acute leukemia. J Clin Oncol 15 (1997) 557-565
10. McGlave P.B., Shu X.O., Wen W., et al. Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor program. Blood 95 (2000) 2219-2225
11. Ramsay N.K., Kim T.H., McGlave P., et al. Total lymphoid irradiation and cyclophosphamide conditioning prior to bone marrow transplantation for patients with severe aplastic anemia. Blood 62 (1983) 622-626
12. McGlave P., Arthur D., Haake R., et al. Therapy of chronic myelogenous leukemia with allogeneic bone marrow transplantation. J Clin Oncol 5 (1987) 1033-1040
13. Kersey J.H., Weisdorf D., Nesbit M.E., et al. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia. N Engl J Med 317 (1987) 461-467
14. Kim T.H., McGlave P.B., Ramsay N., et al. Comparison of two total body irradiation regimens in allogeneic bone marrow transplantation for acute non-lymphoblastic leukemia in first remission. Int J Radiat Oncol Biol Phys 19 (1990) 889-897
15. Barker J.N., Davies S.M., DeFor T., Ramsay N.K., Weisdorf D.J., and Wagner J.E. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood 97 (2001) 2957-2961
16. Wagner J.E., Rosenthal J., Sweetman R., et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 88 (1996) 795-802
17. Lin D.Y. Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med 16 (1997) 901-910
18. Peto R., and Peto J. Asymptotically efficient rank invariant test procedures. J R Stat Soc A 135 (1972) 185-207
19. Cox D. Regression models and life-tables. J R Stat Soc B 34 (1972) 187-220
20. Morris E.C., Harrison G., Bailey C.C., et al. Prognostic factors and outcome for children after second central nervous system relapse of acute lymphoblastic leukaemia. Br J Haematol 120 (2003) 787-789
21. Woolfrey A.E., Anasetti C., Storer B., et al. Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children. Blood 99 (2002) 2002-2008
22. Afify Z., Hunt L., Green A., Guttridge M., Cornish J., and Oakhill A. Factors affecting the outcome of stem cell transplantation from unrelated donors for childhood acute lymphoblastic leukemia in third remission. Bone Marrow Transplant 35 (2005) 1041-1047
23. Bordigoni P., Esperou H., Souillet G., et al. Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Societe Francaise de Greffe de Moelle study. Br J Haematol 102 (1998) 656-665
24. Borgmann A., Baumgarten E., Schmid H., et al. Allogeneic bone marrow transplantation for a subset of children with acute lymphoblastic leukemia in third remission: a conceivable alternative?. Bone Marrow Transplant 20 (1997) 939-944
25. Yoshihara T., Morimoto A., Kuroda H., et al. Allogeneic stem cell transplantation in children with acute lymphoblastic leukemia after isolated central nervous system relapse: our experiences and review of the literature. Bone Marrow Transplant 37 (2006) 25-31
26. Ness K.K., and Gurney J.G. Adverse late effects of childhood cancer and its treatment on health and performance. Annu Rev Public Health 28 (2007) 279-302
27. Alvarez J.A., Scully R.E., Miller T.L., et al. Long-term effects of treatments for childhood cancers. Curr Opin Pediatr 19 (2007) 23-31
28. Butler R.W., and Haser J.K. Neurocognitive effects of treatment for childhood cancer. Ment Retard Dev Disabil Res Rev 12 (2006) 184-191
29. Duffner P.K. Long-term effects of radiation therapy on cognitive and endocrine function in children with leukemia and brain tumors. Neurologist 10 (2004) 293-310
30. Eapen M., Raetz E., Zhang M.J., et al. Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. Blood 107 (2006) 4961-4967
31. Gaynon P.S., Qu R.P., Chappell R.J., et al. Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse-the Children's Cancer Group Experience. Cancer 82 (1998) 1387-1395
32. Buhrer C., Hartmann R., Fengler R., et al. Superior prognosis in combined compared to isolated bone marrow relapses in salvage therapy of childhood acute lymphoblastic leukemia. Med Pediatr Oncol 21 (1993) 470-476